13F

Stock

Biomarin Pharmaceutical Inc

BMRN · held by 9 managers

Reported value

$260.4M

Holders

9

+3 new · −1 exited

Holders’ est. mark

−$73.4M

Price effect on 5 books still in the name

Largest holder

$232.2M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC4.24M$232.2M−$68.1MAdded$76.2M
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main14.5M$22.8M−$4.8MCut−$5.35M
Swiss Life Asset Management Ltd39.8K$3.45M−$408.3KCut−$316.1K
Marex Group plc11.5K$995.3KNew
Leonteq Securities AG5.83K$505.3K−$34.6KAdded$186.2K
Burton Enright Welch3.82K$330.8K−$40.3KCut−$63.1K

Who left

Positions as of Q2 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.